Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05RTM
|
||||
| Former ID |
DNCL002877
|
||||
| Drug Name |
LEZ763
|
||||
| Indication | Peripheral arterial disease; Type 2 diabetes [ICD9: 443, 250; ICD10:I73, E11] | Phase 1/2 | [523944] | ||
| Company |
Novartis
|
||||
| Target and Pathway | |||||
| Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Modulator | ||
| KEGG Pathway | cAMP signaling pathway | ||||
| Insulin secretion | |||||
| WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.